# China NMPA Drug Inspection - Hebei Pengsheng Traditional Chinese Medicine Pieces Co., Ltd. - Traditional Chinese Medicine Decoction Pieces

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/hebei-pengsheng-traditional-chinese-medicine-pieces-co-ltd/c3166f90-fb9c-4e00-b170-b45d9242f790/
Source feed: China

> China NMPA drug inspection for Hebei Pengsheng Traditional Chinese Medicine Pieces Co., Ltd. published October 30, 2017. Drug: Traditional Chinese Medicine Decoction Pieces. The Shandong Provincial Food and Drug Administration (SFDA) issued an announcement on October 30, 2017, detailing signif

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from Shandong Provincial Food and Drug Administration Regarding 31 Batches of Chinese Herbal Medicine Pieces Failing Quality Inspection (Issue No. 7, 2017)
- Company Name: Hebei Pengsheng Traditional Chinese Medicine Pieces Co., Ltd.
- Publication Date: 2017-10-30
- Drug Name: Traditional Chinese Medicine Decoction Pieces
- Inspection Finding: Quality issues, unqualified items including characters and identification
- Action Taken: Control measures such as sealing, seizing, suspending sales, and product recall were taken; cases were filed for investigation and punishment
- Summary: The Shandong Provincial Food and Drug Administration (SFDA) issued an announcement on October 30, 2017, detailing significant findings regarding Traditional Chinese Medicine (TCM) decoction pieces. Following comprehensive tests by eight drug testing institutions, 31 batches of TCM decoction pieces produced by 22 companies, including prominent names such as Bozhou Haomen TCM Decoction Pieces Co., Ltd., Heze Jianmin TCM Decoction Pieces Co., Ltd., and Hubei Daodi Medicinal Materials Technology Co., Ltd., were declared unqualified or substandard. Issues were identified in various TCM types, including Bletilla striata and Pheretima aspergillum. Operating under the national regulatory framework, the SFDA mandated immediate and stringent actions. Municipal food and drug administrations were directed to implement control measures such as sealing, seizing, suspending sales, and recalling the substandard drugs. Legal cases have been initiated against the responsible manufacturers and sampled units. Additionally, municipal bureaus are required to enhance supervision of these products and companies, ensuring thorough investigations into the root causes of the deficiencies and the prompt implementation of effective rectification measures to mitigate potential risks to public health and safety.

Company: https://www.globalkeysolutions.net/companies/hebei-pengsheng-traditional-chinese-medicine-pieces-co-ltd/98ab9f95-1170-4dd9-a3fe-9384aa6b1d3c/